New opportunities for correction of hormonal disorders and oxidative stress in women with genital endometriosis

Halyna Semenyna, M.I. Hrytsko, M.V. Doroshenko-Kravchyk, О.О. Коrytko, Тетяна Фартушок
In: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · 2024 · vol. 20(1) , pp. 41–47 · doi:10.22141/2224-0721.20.1.2024.1356 · W4392343148
article OA: diamond CC0 ⤵ 3 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Supplementing genital endometriosis treatment with superoxide dismutase, resveratrol, and zinc improved pain, quality of life, and antioxidant markers compared to standard therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 ⓘ

The paper evaluated, in 37 women of reproductive age with genital endometriosis, whether supplementing a guideline-based treatment regimen with a combined drug containing superoxide dismutase, resveratrol, and zinc improves oxidative-stress related and symptom outcomes, compared with a traditional regimen in 39 women and a reference group of 30 healthy women. Blood serum markers of lipid peroxidation (diene conjugates and malondialdehyde) and antioxidant defense (superoxide dismutase and glutathione peroxidase) were assessed, and pain-related quality of life was measured using a Visual Analogue Scale, with results analyzed using StatSoft Statistica. The supplemented-treatment group reported complete disappearance of pain in all women with stage 1 disease, substantial pain reductions across stages 2 and 3, reduced pain during intercourse, improved work capacity and decreased perimenstrual irritability/anxiety, and no side effects were noted. The authors conclude the approach significantly improves lipid peroxidation and antioxidant defense compared to traditional treatment, though the study’s stated limitation is the relatively small sample size without explicit blinding details. This paper is centrally about endometriosis — it focuses on oxidative stress correction (superoxide dismutase, resveratrol, zinc) alongside hormonal and antioxidant mechanisms to improve pain in women with genital endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background. Genital endometriosis is one of the most urgent problems of modern gynecology. Considering oxidative stress as a pathogenetic link of endometriosis, we believe it reasonable to use a combined drug containing superoxide dismutase, resveratrol, and zinc. The purpose of the work was to evaluate the effectiveness of the treatment for genital endometriosis supplemented with the use of superoxide dismutase, resveratrol, and zinc, taking into account the leading pathophysiological links of the pathology. Materials and methods. Thirty-seven women of reproductive age with genital endometriosis were under observation. Treatment in the first group was carried out in accordance with the Guideline Development Group recommendations. Thirty-nine women of the second group additionally received a drug containing superoxide dismutase, resveratrol, and zinc. The control group included 30 healthy women. The state of lipid peroxidation processes was assessed by the level of diene conjugates and malondialdehyde in the blood serum and the antioxidant defense system by the content of superoxide dismutase and glutathione peroxidase. To monitor the patients’ quality of life, pain syndrome was studied using the Visual Analogue Scale. Statistical processing of the obtained data was carried out by means of the standard StatSoft Statistica for Windows 13.0 program pac­kage. Results. The assessment of the pain syndrome in the second group showed that it completely disappeared in women with the first stage of the disease. Among patients with the second stage, pain disappeared in 8 cases, 3 patients had a decrease from severe to mild pain. At the third stage, pain disappeared completely in 5 women, in 4 cases, it decreased from severe to mild, and in one woman, the pain decreased from unbearable to mild. All patients of the second group noted a decrease in pain during intercourse, and in the first stage — its absence, an increase in work capacity (r = 0.64, p < 0.01), a decrease in irritability and anxiety in the perimenstrual period (r = –0.59, p < 0.05) and overall satisfaction with the treatment result. Side effects were not noted in any of the patients. Conclusions. Improving treatment for genital endometriosis by supplementing therapy with superoxide dismutase, resveratrol, and zinc is pathogenetically justified, as it has a significant positive effect on the lipid peroxidation and antioxidant defense system, compared to the traditional treatment regimen.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK